T

Talkmed Group Ltd
SGX:5G3

Watchlist Manager
Talkmed Group Ltd
SGX:5G3
Watchlist
Price: 0.44 SGD -2.22%
Market Cap: 584.2m SGD
Have any thoughts about
Talkmed Group Ltd?
Write Note
Section:
 

Profitability Summary

Talkmed Group Ltd's profitability score is 78/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

78/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

78/100
Profitability
Score
78/100
Profitability
Score
High Profitability Stocks
Health Care Industry

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Talkmed Group Ltd

Revenue
79.1m SGD
Operating Expenses
-46.3m SGD
Operating Income
32.8m SGD
Other Expenses
-5.1m SGD
Net Income
27.7m SGD

Margins Comparison
Talkmed Group Ltd Competitors

Country Company Market Cap Operating
Margin 		Net
Margin
SG
Talkmed Group Ltd
SGX:5G3
597m SGD
41%
35%
US
Cigna Corp
NYSE:CI
95B USD
4%
1%
US
Cigna Group
XMUN:CGN
89.7B EUR
4%
1%
US
CVS Health Corp
NYSE:CVS
68B USD
3%
1%
DE
Fresenius Medical Care AG
XMUN:FME
23.5B EUR
7%
3%
US
Laboratory Corporation of America Holdings
NYSE:LH
20.4B USD
9%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.7B EUR
6%
-5%
US
Quest Diagnostics Inc
NYSE:DGX
18.1B USD
14%
9%
US
DaVita Inc
NYSE:DVA
13.1B USD
15%
7%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR
7%
3%
US
Chemed Corp
NYSE:CHE
8.5B USD
17%
13%
T
Talkmed Group Ltd
SGX:5G3
Country SG
Market Cap 597m SGD
Operating Margin
41%
Net Margin
35%
Cigna Corp
NYSE:CI
Country US
Market Cap 95B USD
Operating Margin
4%
Net Margin
1%
C
Cigna Group
XMUN:CGN
Country US
Market Cap 89.7B EUR
Operating Margin
4%
Net Margin
1%
CVS Health Corp
NYSE:CVS
Country US
Market Cap 68B USD
Operating Margin
3%
Net Margin
1%
Fresenius Medical Care AG
XMUN:FME
Country DE
Market Cap 23.5B EUR
Operating Margin
7%
Net Margin
3%
Laboratory Corporation of America Holdings
NYSE:LH
Country US
Market Cap 20.4B USD
Operating Margin
9%
Net Margin
3%
Fresenius SE & Co KGaA
XETRA:FRE
Country DE
Market Cap 18.7B EUR
Operating Margin
6%
Net Margin
-5%
Quest Diagnostics Inc
NYSE:DGX
Country US
Market Cap 18.1B USD
Operating Margin
14%
Net Margin
9%
DaVita Inc
NYSE:DVA
Country US
Market Cap 13.1B USD
Operating Margin
15%
Net Margin
7%
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Country DE
Market Cap 11.8B EUR
Operating Margin
7%
Net Margin
3%
Chemed Corp
NYSE:CHE
Country US
Market Cap 8.5B USD
Operating Margin
17%
Net Margin
13%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Talkmed Group Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SG
Talkmed Group Ltd
SGX:5G3
597m SGD
33%
26%
40%
154%
US
Cigna Corp
NYSE:CI
95B USD
7%
2%
10%
7%
US
Cigna Group
XMUN:CGN
89.7B EUR
7%
2%
10%
7%
US
CVS Health Corp
NYSE:CVS
68B USD
7%
2%
7%
4%
DE
Fresenius Medical Care AG
XMUN:FME
23.5B EUR
4%
2%
5%
3%
US
Laboratory Corporation of America Holdings
NYSE:LH
20.4B USD
5%
2%
8%
5%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.7B EUR
-6%
-2%
3%
1%
US
Quest Diagnostics Inc
NYSE:DGX
18.1B USD
13%
6%
10%
8%
US
DaVita Inc
NYSE:DVA
13.1B USD
104%
5%
13%
10%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR
4%
2%
5%
3%
US
Chemed Corp
NYSE:CHE
8.5B USD
27%
18%
29%
22%
T
Talkmed Group Ltd
SGX:5G3
Country SG
Market Cap 597m SGD
ROE
33%
ROA
26%
ROCE
40%
ROIC
154%
Cigna Corp
NYSE:CI
Country US
Market Cap 95B USD
ROE
7%
ROA
2%
ROCE
10%
ROIC
7%
C
Cigna Group
XMUN:CGN
Country US
Market Cap 89.7B EUR
ROE
7%
ROA
2%
ROCE
10%
ROIC
7%
CVS Health Corp
NYSE:CVS
Country US
Market Cap 68B USD
ROE
7%
ROA
2%
ROCE
7%
ROIC
4%
Fresenius Medical Care AG
XMUN:FME
Country DE
Market Cap 23.5B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Laboratory Corporation of America Holdings
NYSE:LH
Country US
Market Cap 20.4B USD
ROE
5%
ROA
2%
ROCE
8%
ROIC
5%
Fresenius SE & Co KGaA
XETRA:FRE
Country DE
Market Cap 18.7B EUR
ROE
-6%
ROA
-2%
ROCE
3%
ROIC
1%
Quest Diagnostics Inc
NYSE:DGX
Country US
Market Cap 18.1B USD
ROE
13%
ROA
6%
ROCE
10%
ROIC
8%
DaVita Inc
NYSE:DVA
Country US
Market Cap 13.1B USD
ROE
104%
ROA
5%
ROCE
13%
ROIC
10%
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Country DE
Market Cap 11.8B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Chemed Corp
NYSE:CHE
Country US
Market Cap 8.5B USD
ROE
27%
ROA
18%
ROCE
29%
ROIC
22%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Summary
5G3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
5G3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
5G3 stock valuation using valuation multiples.
Wall Street Estimates
5G3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
5G3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 197,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.